2.3. Haplotypes of Single Nucleotide Polymorphisms in APEX1 as Well as in LIG3 Modulate the Risk of IR Occurrence in NAFLD Patients. This evidence concerns the gene LIG3 and metabolic dysfunction-associated steatotic liver disease.